This episode delves into the SUPERDURA trial, a multicenter, randomized, non-inferiority clinical trial evaluating the statistical analysis plan for comparing active subperiosteal versus passive subdural 24-hour drainage after single burr hole evacuation of chronic subdural hematomas. The full text of this study, published in Trials in 2026, outlines the methodology for a population undergoing this common neurosurgical procedure. We discuss the trial's design, the anticipated findings, and the potential clinical implications for improving outcomes in managing chronic subdural hematomas. This information is for educational purposes and does not constitute medical advice.